Citation Impact
Citing Papers
Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms
2008
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
2008
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
2009 Standout
The Tissue-Engineered Vascular Graft—Past, Present, and Future
2015 Standout
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
2010
Bone Morphogenetic Protein (BMP) signaling in development and human diseases
2014 Standout
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Characterization of Wise Protein and Its Molecular Mechanism to Interact with both Wnt and BMP Signals
2009
Inference and analysis of cell-cell communication using CellChat
2021 Standout
Characterization of the Interaction of Sclerostin with the Low Density Lipoprotein Receptor-related Protein (LRP) Family of Wnt Co-receptors
2012
Characterization of the Structural Features and Interactions of Sclerostin
2009
Collateral circulation
2008
The −9247 T/C polymorphism in the SOST upstream regulatory region that potentially affects C/EBPα and FOXA1 binding is associated with osteoporosis
2009
Fracture healing: mechanisms and interventions
2014 Standout
Osteoporosis
2019 Standout
Building bone to reverse osteoporosis and repair fractures
2008
Cartilage tumours and bone development: molecular pathology and possible therapeutic targets
2010
Cancer to bone: a fatal attraction
2011 Standout
Cellular mechanisms of bone remodeling
2010
Roles of individual prolyl‐4‐hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice
2012 StandoutNobel
Genetic evidence that SOST inhibits WNT signaling in the limb
2010
The role of magnesium ions in bone regeneration involves the canonical Wnt signaling pathway
2019 Standout
Bone morphogenetic protein receptors and signal transduction
2009 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes
2010
Update on hypoxia-inducible factors and hydroxylases in oxygen regulatory pathways: from physiology to therapeutics
2017 StandoutNobel
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
2011
Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
2009
Osteocytes, mechanosensing and Wnt signaling
2008
Circulating Sclerostin in Disorders of Parathyroid Gland Function
2011
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
2011
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
2008
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Osteoporosis: now and the future
2011 Standout
Extracellular Matrix Degradation and Remodeling in Development and Disease
2011 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Inflammatory Effects of High and Moderate Intensity Exercise—A Systematic Review
2020 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Risk-Adjusted Meta-analysis of 30-Day Mortality of Endovascular Versus Open Repair for Ruptured Abdominal Aortic Aneurysms
2015
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
2012
Lymphocytes and ischemia-reperfusion injury
2008
Role of Wnt signaling in fracture healing
2014
Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases
2008
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
2012 Standout
Merging molecular imaging and RNA interference: Early experience in live animals
2008
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
2014
Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours
2010
What old means to bone
2010 Standout
Epigenetics in atherosclerosis and inflammation
2010
Agonists and Antagonists of TGF-β Family Ligands
2016
CD39 and CD73 in immunity and inflammation
2013 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease
2016 Standout
Mitochondrial TCA cycle metabolites control physiology and disease
2020 Standout
Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin
2007
Genetics of osteoporosis: accelerating pace in gene identification and validation
2009
Knocking down barriers: advances in siRNA delivery
2009 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Vascular Growth in Ischemic Limbs: A Review of Mechanisms and Possible Therapeutic Stimulation
2008
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Systemic Administration of Sclerostin Antibody Enhances Bone Repair in a Critical-Sized Femoral Defect in a Rat Model
2013
Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway
2018
Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways
2010
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
2016
The role of the Wnt signaling pathway in osteoblast commitment and differentiation
2007
Unraveling metalloproteinase function in skeletal biology and disease using genetically altered mice
2009
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover
2011
A critical role for macrophages in neovessel formation and the development of stenosis in tissue‐engineered vascular grafts
2011
Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism
2011
Pro-Inflammatory Cytokines TNF-Related Weak Inducer of Apoptosis (TWEAK) and TNFα Induce the Mitogen-Activated Protein Kinase (MAPK)-Dependent Expression of Sclerostin in Human Osteoblasts
2009
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
2008
Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling
2010
Sclerostin: A gem from the genome leads to bone-building antibodies
2010
The roles of interleukins in perfusion recovery after peripheral arterial disease
2018
Control of the SOST Bone Enhancer by PTH Using MEF2 Transcription Factors
2007
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice
2009
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
The amazing osteocyte
2010 Standout
BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway
2008
Enchondromatosis: insights on the different subtypes.
2010
Wide Genetic Variation in the Native Pial Collateral Circulation is a Major Determinant of Variation in Severity of Stroke
2010
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Works of D. Eefting being referenced
Differences in Mortality, Risk Factors, and Complications After Open and Endovascular Repair of Ruptured Abdominal Aortic Aneurysms
2014
Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention
2006
Assessment of Interobserver Variability and Histologic Parameters to Improve Reliability in Classification and Grading of Central Cartilaginous Tumors
2008
Prolonged In Vivo Gene Silencing by Electroporation-Mediated Plasmid Delivery of Small Interfering RNA
2007
Anti–MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In Vivo
2006
Natural Killer Cells and CD4 + T-Cells Modulate Collateral Artery Development
2007
Wnt but Not BMP Signaling Is Involved in the Inhibitory Action of Sclerostin on BMP-Stimulated Bone Formation
2006